75
Participants
Start Date
April 30, 2005
Primary Completion Date
December 31, 2007
Study Completion Date
December 31, 2007
Thymoglobulin
Antibody inductions with tacrolimus and corticosteroid sparing maintenance therapy
Corticosteroid
For a minimum of 3 months
Tacrolimus
Between Day 3 the last dose of Thymoglobulin
Mycophenolate Mofetil
for at least 1 month posttransplant
Mount Sinai Medical Center, New York
VCU Medical Center, Richmond
Mayo Clinic Jacksonville, Jacksonville
University of Miami, Miami
University of Alabama, Birmingham, Birmingham
University of Cincinnati Medical Center, Cincinnati
Fairview University Medical Center, Minneapolis
Washington University Medical Center, St Louis
University of Nebraska, Omaha
Baylor University Medical Center, Dallas
University of Texas Health Science Center at San Antonio, University Hospital, San Antonio
University of Colorado Hospital and Health Sciences Center, Denver
USC University Hospital, Los Angeles
University of California, San Fransisco Hospital, San Francisco
Toronto University Hospital - UHN, Toronto
Royal Victoria Hospital, Montreal
Genzyme, a Sanofi Company
INDUSTRY